Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Cardiology | Dermatology | Family Medicine | Geriatrics | Gynecology | Oncology | Pathology | Pharmacy | Conference News

Back to Journal Articles

AACR: Statin Use Not Likely to Affect Overall Cancer Risk

Last Updated: November 10, 2010.

 

But long-term use may reduce risk for endometrial cancer, melanoma, and non-Hodgkin's lymphoma

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Long-term use of statins for cholesterol control is unlikely to significantly increase or decrease overall cancer risk but may reduce the risk for some individual cancers, according to a study presented at the American Association for Cancer Research's Frontiers in Cancer Prevention Research Conference, held from Nov. 7 to 10 in Philadelphia.

WEDNESDAY, Nov. 10 (HealthDay News) -- Long-term use of statins for cholesterol control is unlikely to significantly increase or decrease overall cancer risk but may reduce the risk for some individual cancers, according to a study presented at the American Association for Cancer Research's Frontiers in Cancer Prevention Research Conference, held from Nov. 7 to 10 in Philadelphia.

Eric J. Jacobs, Ph.D., of the American Cancer Society in Atlanta, and colleagues analyzed the incidence of 10 common cancers and the overall cancer incidence in 133,255 participants in the Cancer Prevention Study II Nutrition Cohort. Study participants, who had completed questionnaires about a range of lifestyle and medical factors, including use of cholesterol-lowering drugs, were followed from 1997 to 2007, during which time more than 15,000 received a cancer diagnosis.

The researchers found that current use of cholesterol-lowering drugs (mainly statins) for five years or longer was not associated with risk for overall cancer incidence (relative risk [RR], 0.97), or for incidence of bladder, breast, colorectal, lung, pancreatic, prostate, or renal cell cancer. However, cholesterol-lowering drug use was associated with lowered risk of endometrial cancer (RR, 0.61), non-Hodgkin's lymphoma (RR, 0.73), and melanoma (RR, 0.81).

"These results suggest that long-term use of statins is unlikely to substantially increase or decrease overall cancer risk. However, associations between long-term statin use and risk of endometrial cancer, melanoma, and non-Hodgkin's lymphoma deserve further investigation," the authors write.

Press Release
More Information

Copyright © 2010 HealthDay. All rights reserved.


Previous: AACR: Exercise Associated With Lower Endometrial Cancer Risk Next: Cell Phone Messaging Improves HIV Treatment in Kenya

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.